Arkansas Development Finance Authority
VC Fund
Little Rock, United States
Arkansas Development Finance Authority is a VC fund in Little Rock focused on Medical and Biotechnology. "ADFA is a public body politic and corporate, created in 1985 as successor to the Arkansas Housing Development Agency created in 1977. ADFA’s enabling legislation authorizes it to borrow money and issue bonds to provide sufficient funding for financing affordable housing, various business and economic development projects, and capitalimprovements for state agencies. "
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Arkansas Development Finance Authority invests in
Stages Arkansas Development Finance Authority invests in
Countries Arkansas Development Finance Authority invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Medical 2 (33%)
- Biotechnology 2 (33%)
- Manufacturing 2 (33%)
- Fashion 1 (17%)
- E-Commerce 1 (17%)
Stage
- Funding Round 2 (33%)
- Seed 1 (17%)
- Pre-Seed 1 (17%)
- Post-IPO Debt 1 (17%)
- Venture - Series Unknown 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Robert Arrington
President
|
President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
United States Steel Corporation is an integrated steel producer with major production operations in the United States, Canada and Central Europe and an annual raw steelmaking capability of 27 million net tons. The company manufactures a wide range of value-added steel sheet and tubular products for the automotive, appliance, container, industrialmachinery, construction, and oil and gas industries. | $240M / Post-IPO Debt / May 18, 2023 | |
|
|
Pacific GeneTech develops and commercializes first-in-class or best-in-class vaccines for areas of high unmet or underserved needs in food safety and livestock animal health. The global animal vaccine market is a valuable opportunity and is expected to reach US$20.6 billion by 2021. Livestock illness can lead to human infections, poor feedconversion, or loss of animals, making it a significant economic burden to producers.Founded in 2009, Pacific GeneTech focuses on developing and commercializing vaccines for the livestock industry through their proprietary Aegis platform which have broad cross-protection. In 2012, they acquired the exclusive global rights to Hercules Adjuvant Delivery System to enhance Aegis developed vaccines and explore partnership opportunities for other vaccine products. Pacific GeneTech has out-licensed two of its leading poultry vaccines addressing economically important gastro-intestinal pathogens and has out-licensed its Hercules adjuvant for use in third-party vaccines. Vaccines for other pathogens and animal species are under development. Pacific GeneTech is developing other applications for its Hercules adjuvant delivery system. Pacific GeneTech, through its affiliate company, PGTx, has commenced programs with collaborators addressing human dysentery. | $10M / Venture - Series Unknown / Aug 24, 2022 | |
|
|
Pacific GeneTech develops and commercializes first-in-class or best-in-class vaccines for areas of high unmet or underserved needs in food safety and livestock animal health. The global animal vaccine market is a valuable opportunity and is expected to reach US$20.6 billion by 2021. Livestock illness can lead to human infections, poor feedconversion, or loss of animals, making it a significant economic burden to producers.Founded in 2009, Pacific GeneTech focuses on developing and commercializing vaccines for the livestock industry through their proprietary Aegis platform which have broad cross-protection. In 2012, they acquired the exclusive global rights to Hercules Adjuvant Delivery System to enhance Aegis developed vaccines and explore partnership opportunities for other vaccine products. Pacific GeneTech has out-licensed two of its leading poultry vaccines addressing economically important gastro-intestinal pathogens and has out-licensed its Hercules adjuvant for use in third-party vaccines. Vaccines for other pathogens and animal species are under development. Pacific GeneTech is developing other applications for its Hercules adjuvant delivery system. Pacific GeneTech, through its affiliate company, PGTx, has commenced programs with collaborators addressing human dysentery. | $10M / Seed / Aug 24, 2022 | |
|
|
BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow. | $35M / Jun 10, 2014 | |
|
|
Ascendant Dx provides develop proteomics-based diagnostic tests. They acquire promising new proteomic research in partnership with leading academic and medical research institutions, and thru clinical research and commercial partnerships, validate and bring these new tests. | $2M / May 20, 2014 | |
|
|
We are enabling small fashion boutiques to aggregate products and sell in the social media space.Consumers can find, follow & shop their favorite boutiques in their favorite cities, on the go!Today, online sales are nearing 50% of all U.S. retail sales, and being trendy is a rapidly growing trend!Online clothing sales account for over25% of all online sales, with a trending 95% growth year-on-year. However, these figures are in the traditional e-commerce space. And, we're interested in the future of making a sale...SOCIAL COMMERCE. Selling right in the social space, and it's just beginning to take off!74% of consumers rely on social networks to guide their purchase decisions, and the switch to s-commerce is due to a few key variables:- more time spent on social networks- brands getting outside of fan pages and targeting consumers in their direct news feeds- technology advances such as geo-locationSo what does all this have to do with small fashion boutiques?THE PROBLEM: Small fashion boutiques are a major market niche across the map & the majority are not selling online or manage a one-dimensional online presence. The very few that have tapped in to selling limited quantities in the social space manage a time-consuming and manual selling system via facebook. WHY are boutiques not online?- Limited inventory and budgets for an e-commerce site- Limited resources to effectively implement and manage a social commerce selling systemWe are catapulting small fashion boutiques to sell in the social space with an easy and efficient platform! | $150K / Pre-Seed / Nov 08, 2012 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Arkansas Development Finance Authority invest in?
Arkansas Development Finance Authority invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Funding Round and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Arkansas Development Finance Authority?
Public channels for Arkansas Development Finance Authority include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Arkansas Development Finance Authority?
The team at Arkansas Development Finance Authority includes Robert Arrington (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!